. 2022 Nov 19;23(1):372.

doi: 10.1186/s12882-022-02987-1.

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

Andrea K Viecelli^{1

2

3}, Armando Teixeira-Pinto⁴, Andrea Valks⁵, Richard Baer⁶, Roy Cherian⁷, Pietro E Cippà⁸, Jonathan C Craig⁹, Ranil DeSilva¹⁰, Allison Jaure¹¹, David W Johnson^{12

13

5}, Charani Kiriwandeniya⁵, Pascal Kopperschmidt¹⁴, Wen-J Liu¹⁵, Timmy Lee¹⁶, Charmaine Lok¹⁷, Krishan Madhan¹⁸, Alistair R Mallard⁵, Veronica Oliver¹², Kevan R Polkinghorne^{19

20

21}, Rob R Quinn²², Donna Reidlinger⁵, Matthew Roberts²³, Bénédicte Sautenet²⁴, Lai Seong Hooi¹⁵, Rob Smith²⁵, Maarten Snoeijs²⁶, Jan Tordoir²⁶, Tushar J Vachharajani^{27

28}, Raymond Vanholder²⁹, Liza A Vergara⁵, Martin Wilkie³⁰, Bing Yang³¹, Theodore H Yuo¹⁰, Li Zou³¹, Carmel M Hawley^{12

13

5}; VALID Investigator Team

Collaborators, Affiliations

Collaborators

VALID Investigator Team:
Laura Robison, Alyssa Welch, Sunil V Badve, Neil Boudville, Katrina Campbell, Yeoungjee Cho, Michael Collins, Magid A Fahim, Meg Jardine, Dianne Du Toit, Michelle Mayne, Kim Stevenson, Rachel James, Quynh Vu, Karyn Allen, Leanne Glancy, Jijo Kumbikkal, Sharan Burton, Lisa Gordon, Kylee McCarthy, Cathy Forrester, Sally Lima, Olivier Bourgault, Claire Drouault, Fanny Teasdale, Liu Wen Jiun, Jamian Abidin, Cheng Jin Kiang, Lee Soon Leng, Yuana Mohd Yusoff, Adriana Ciochina, Magda van Loon, Ronald Ophelders, Marie-Jose Vleugels, Paolo Ferrari, Marie-Ève Brodeur, Davide Giunzioni, Christine Bressan Molfese, Christopher Blackwell, Louese Dunn, Laura Gillis, Barry Gray, Sarah Jenkins

Affiliations

¹ Department of Nephrology, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD, 4102, Australia. andrea.viecelli@health.qld.gov.au.
² The Translational Research Institute, Brisbane, Australia. andrea.viecelli@health.qld.gov.au.
³ Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia. andrea.viecelli@health.qld.gov.au.
⁴ Centre for Kidney Research, School of Public Health, The University of Sydney, Sydney, Australia.
⁵ Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
⁶ Mater Hospital Brisbane, Brisbane, Queensland, Australia.
⁷ Mackay Base Hospital, Mackay, Australia.
⁸ Division of Nephrology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
⁹ Flinders University, Adelaide, Australia.
¹⁰ University of Pittsburgh, Pittsburgh, PA, USA.
¹¹ The University of Sydney, Sydney, Australia.
¹² Department of Nephrology, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD, 4102, Australia.
¹³ The Translational Research Institute, Brisbane, Australia.
¹⁴ Patient Partner, Fresenius Medical Care, Schweinfurt, Germany.
¹⁵ Sultanah Aminah, Johor Bahru, Malaysia.
¹⁶ Veterans Affairs Medical Center, Birmingham, AL, USA.
¹⁷ University of Toronto, Toronto, Ontario, Canada.
¹⁸ Hervey Bay Hospital, Urraween, Queensland, Australia.
¹⁹ Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, VIC, Australia.
²⁰ Department of Medicine, Monash University, Clayton, VIC, Australia.
²¹ Department of Epidemiology & Preventive Medicine, Monash University, Clayton, VIC, Australia.
²² Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
²³ Eastern Health Clinical School, Monash University, Melbourne, Australia.
²⁴ Tours University, Tours, France.
²⁵ Patient Partner, Royal Darwin Hospital, Darwin, Australia.
²⁶ Maastricht University Medical Center, Maastricht, Netherlands.
²⁷ Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, USA.
²⁸ Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, USA.
²⁹ Ghent University, Ghent, Belgium.
³⁰ Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
³¹ Peking University People's Hospital, Beijing, China.

PMID: 36402958
PMCID: PMC9675211
DOI: 10.1186/s12882-022-02987-1

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

Andrea K Viecelli et al. BMC Nephrol. 2022.

. 2022 Nov 19;23(1):372.

doi: 10.1186/s12882-022-02987-1.

Authors

Collaborators

VALID Investigator Team:
Laura Robison, Alyssa Welch, Sunil V Badve, Neil Boudville, Katrina Campbell, Yeoungjee Cho, Michael Collins, Magid A Fahim, Meg Jardine, Dianne Du Toit, Michelle Mayne, Kim Stevenson, Rachel James, Quynh Vu, Karyn Allen, Leanne Glancy, Jijo Kumbikkal, Sharan Burton, Lisa Gordon, Kylee McCarthy, Cathy Forrester, Sally Lima, Olivier Bourgault, Claire Drouault, Fanny Teasdale, Liu Wen Jiun, Jamian Abidin, Cheng Jin Kiang, Lee Soon Leng, Yuana Mohd Yusoff, Adriana Ciochina, Magda van Loon, Ronald Ophelders, Marie-Jose Vleugels, Paolo Ferrari, Marie-Ève Brodeur, Davide Giunzioni, Christine Bressan Molfese, Christopher Blackwell, Louese Dunn, Laura Gillis, Barry Gray, Sarah Jenkins

Affiliations

¹ Department of Nephrology, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD, 4102, Australia. andrea.viecelli@health.qld.gov.au.
² The Translational Research Institute, Brisbane, Australia. andrea.viecelli@health.qld.gov.au.
³ Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia. andrea.viecelli@health.qld.gov.au.
⁴ Centre for Kidney Research, School of Public Health, The University of Sydney, Sydney, Australia.
⁵ Australasian Kidney Trials Network, The University of Queensland, Brisbane, Australia.
⁶ Mater Hospital Brisbane, Brisbane, Queensland, Australia.
⁷ Mackay Base Hospital, Mackay, Australia.
⁸ Division of Nephrology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
⁹ Flinders University, Adelaide, Australia.
¹⁰ University of Pittsburgh, Pittsburgh, PA, USA.
¹¹ The University of Sydney, Sydney, Australia.
¹² Department of Nephrology, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD, 4102, Australia.
¹³ The Translational Research Institute, Brisbane, Australia.
¹⁴ Patient Partner, Fresenius Medical Care, Schweinfurt, Germany.
¹⁵ Sultanah Aminah, Johor Bahru, Malaysia.
¹⁶ Veterans Affairs Medical Center, Birmingham, AL, USA.
¹⁷ University of Toronto, Toronto, Ontario, Canada.
¹⁸ Hervey Bay Hospital, Urraween, Queensland, Australia.
¹⁹ Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, VIC, Australia.
²⁰ Department of Medicine, Monash University, Clayton, VIC, Australia.
²¹ Department of Epidemiology & Preventive Medicine, Monash University, Clayton, VIC, Australia.
²² Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
²³ Eastern Health Clinical School, Monash University, Melbourne, Australia.
²⁴ Tours University, Tours, France.
²⁵ Patient Partner, Royal Darwin Hospital, Darwin, Australia.
²⁶ Maastricht University Medical Center, Maastricht, Netherlands.
²⁷ Department of Kidney Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, USA.
²⁸ Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, USA.
²⁹ Ghent University, Ghent, Belgium.
³⁰ Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
³¹ Peking University People's Hospital, Beijing, China.

PMID: 36402958
PMCID: PMC9675211
DOI: 10.1186/s12882-022-02987-1

Abstract

Background: A functioning vascular access (VA) is crucial to providing adequate hemodialysis (HD) and considered a critically important outcome by patients and healthcare professionals. A validated, patient-important outcome measure for VA function that can be easily measured in research and practice to harvest reliable and relevant evidence for informing patient-centered HD care is lacking. Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) aims to assess the accuracy and feasibility of measuring a core outcome for VA function established by the international Standardized Outcomes in Nephrology (SONG) initiative.

Methods: VALID is a prospective, multi-center, multinational validation study that will assess the accuracy and feasibility of measuring VA function, defined as the need for interventions to enable and maintain the use of a VA for HD. The primary objective is to determine whether VA function can be measured accurately by clinical staff as part of routine clinical practice (Assessor 1) compared to the reference standard of documented VA procedures collected by a VA expert (Assessor 2) during a 6-month follow-up period. Secondary outcomes include feasibility and acceptability of measuring VA function and the time to, rate of, and type of VA interventions. An estimated 612 participants will be recruited from approximately 10 dialysis units of different size, type (home-, in-center and satellite), governance (private versus public), and location (rural versus urban) across Australia, Canada, Europe, and Malaysia. Validity will be measured by the sensitivity and specificity of the data acquisition process. The sensitivity corresponds to the proportion of correctly identified interventions by Assessor 1, among the interventions identified by Assessor 2 (reference standard). The feasibility of measuring VA function will be assessed by the average data collection time, data completeness, feasibility questionnaires and semi-structured interviews on key feasibility aspects with the assessors.

Discussion: Accuracy, acceptability, and feasibility of measuring VA function as part of routine clinical practice are required to facilitate global implementation of this core outcome across all HD trials. Global use of a standardized, patient-centered outcome measure for VA function in HD research will enhance the consistency and relevance of trial evidence to guide patient-centered care.

Trial registration: Clinicaltrials.gov: NCT03969225. Registered on 31st May 2019.

Keywords: Arteriovenous fistula; Arteriovenous graft; Central venous catheter; Core outcome; Feasibility; Hemodialysis; Implementation; Patient engagement; Validation; Vascular access.

PubMed Disclaimer

Conflict of interest statement

RRQ holds a patent for DMAR, a data collection platform for Q1 in dialysis and consultancy / research support Baxter Corporation. KM has consultancy fees from Otsuka Australia Pharmaceutical Pty Ltd., Support for professional meeting attendance from Amgen Australia and Roche Australia. DWJ has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca, Bayer, and AWAK, speaker’s honoraria from ONO and BI & Lilly, and travel sponsorships from Ono and Amgen. He is a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant.

All other authors have no competing interests to declare.

Figures

**Fig. 1**
Study Schema. Abbreviations: HD – Hemodialysis; VA – Vascular Access. The study design aligns with the STARD 2015 guidelines: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies [29]

**Fig. 2**
Study Governance Structure. Abbreviations: AKTN – Australasian Kidney Trials Network; UQ – University of Queensland, Australia

See this image and copyright information in PMC

References

1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi: 10.1016/S0140-6736(14)61601-9. - DOI - PubMed
1. Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int. 1998;54(4):1029–1040. doi: 10.1046/j.1523-1755.1998.00122.x. - DOI - PubMed
1. Arora P, Kausz AT, Obrador GT, Ruthazer R, Khan S, Jenuleson CS, et al. Hospital utilization among chronic dialysis patients. J Am Soc Nephrol. 2000;11(4):740–746. doi: 10.1681/ASN.V114740. - DOI - PubMed
1. Manns B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, et al. Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol. 2005;16(1):201–209. doi: 10.1681/ASN.2004050355. - DOI - PubMed
1. Taylor MJ, Hanson CS, Casey JR, Craig JC, Harris D, Tong A. "You know your own fistula, it becomes a part of you"-Patient perspectives on vascular access: A semistructured interview study. Hemodial Int. 2015;20(1):5–14. doi: 10.1111/hdi.12340. - DOI - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

Collaborators

Affiliations

Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Associated data

LinkOut - more resources

Full Text Sources

Medical